Seventure Partners
Seventure Partners is a European venture capital firm founded in 1997 and based in Paris, with €1 billion under management as of June 2024. It actively funds innovative companies in the fields of Digital technologies and Life sciences, supporting their growth and contributing to economic development in Europe.
Key facts
Recent exits
Coverage notes
9 funds tracked, 133 portfolio companies (123 active · 10 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Seventure Partners has raised, with its portfolio companies. Hand-checked from public filings.
Blue Forward FundGrowth2022 · 4yr€130M10 active
Unrealized
10 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Chemdoc | Energy | France | 2023 |
| Dielen Laboratoire | Energy | France | 2020 |
| Eauzons! | Energy | France | 2023 |
| GIT | Energy | Canada | 2022 |
| GOA Ventures | Energy | Netherlands | 2022 |
| Inalve | Energy | France | 2022 |
| Seaweed Concept | Energy | France | 2023 |
| Sinay | Energy | France | 2022 |
| Syroco | Energy | France | 2025 |
| vorteX-io | Energy | France | 2026 |
Digital Opportunities Fund IIVC2020 · 6yr€80M9 active · 1 realized
Unrealized
9 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Citalid | Fintech | France | 2022 |
| Glopal | E-commerce | France | 2023 |
| Idnow | Fintech | Germany | 2026 |
| Mediads | E-commerce | France | 2026 |
| Opencell | Fintech | France | 2021 |
| Otoqi | E-commerce | France | 2020 |
| Pitchy | Business Services | France | 2023 |
| Reelevant | E-commerce | France | 2026 |
| Wallix | Business Services | France | 2023 |
Health for Life Capital IIVC2020 · 6yr€200M6 active
Unrealized
6 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Nanobiotix | Healthcare | France | 2023 |
| RevivBio | Biotech | US | 2023 |
| STRING BIO | Healthcare | Inde | 2023 |
| TIBOT | Healthcare | France | 2020 |
| Tubulis | Healthcare | Germany | 2021 |
| Virovet | Healthcare | Belgium | 2023 |
Sport & Performance CapitalVC2019 · 7yr€80M17 active
Unrealized
17 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Anybuddy | Consumer | France | 2025 |
| Baouw | Consumer | France | 2023 |
| bsport | Consumer | France | 2023 |
| Clim8 | Consumer | France | 2020 |
| Ekstere | Consumer | France | 2025 |
| Exo | Consumer | France | 2024 |
| Freejump | Consumer | France | 2022 |
| Geovelo | Consumer | France | 2022 |
| Hardloop | Consumer | France | 2019 |
| Karius | Biotech | US | 2020 |
| Karmen | Fintech | France | 2022 |
| Kinomap | Consumer | France | 2019 |
| Move’n See | Consumer | France | 2019 |
| Skillcorner | Consumer | France | 2020 |
| SportEasy | Consumer | France | 2019 |
| The Sancturary Group | Consumer | France | 2022 |
| Zenniz | Consumer | Finlande | 2026 |
AVF FundVC2018 · 8yr€24M1 active
Digital Opportunities FundVC2017 · 9yr€56M19 active · 3 realized
Unrealized
19 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Aston Itrade Finance | Fintech | France | 2020 |
| Flexvelop | Fintech | Germany | 2020 |
| Hackuity | Business Services | France | 2022 |
| Hepster | Fintech | Germany | 2020 |
| Homerez | Business Services | France | 2013 |
| Ideel | Fintech | France | 2022 |
| Inspecto | Healthcare | Israel | 2022 |
| Izicap | Fintech | France | 2020 |
| Jobteaser | Business Services | France | 2018 |
| Jolimoi | E-commerce | France | 2019 |
| Own Security | Business Services | France | 2022 |
| Rejolt (ex Business... | Fintech | France | 2021 |
| Secure-IC | Business Services | France | 2020 |
| SEKOIA.IO | Business Services | France | 2021 |
| Sentryc | E-commerce | Germany | 2021 |
| Siit | Fintech | France | 2022 |
| Sumup | Fintech | Germany | 2019 |
| TransferGo | Fintech | UK | 2019 |
| YesWeHack | Business Services | France | 2021 |
Realized
3 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| 365Talents | Business Services | France | 2019 | 2026 | Trade Sale | – | |
| Medius (Expensya) | Fintech | France | 2018 | 2023 | Trade Sale | – | |
| Wealthpilot | Fintech | Germany | 2020 | 2025 | Trade Sale | – |
Health for Life CapitalVC2014 · 12yr€160M52 active · 3 realized
Unrealized
52 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Abalos | Biotech | Germany | 2021 |
| Allozymes | Biotech | France | 2022 |
| Anaeropharma | Biotech | Japan | 2021 |
| BiomX | Biotech | Israel | 2017 |
| CardioSecur | MedTech | Germany | 2019 |
| CattleEye | Healthcare | Ireland | 2021 |
| Citryll | Biotech | Netherlands | 2021 |
| Cmbio –... | Biotech | Denmark | 2023 |
| Corpowell (Vecollal) | Biotech | Belgium | 2021 |
| CorWave | MedTech | France | 2019 |
| Cytoki | Biotech | Denmark | 2023 |
| Dermala | Biotech | US | 2020 |
| Dopavision | MedTech | Germany | 2020 |
| Ecto | Healthcare | US | 2021 |
| Eligo | Biotech | France | 2019 |
| Enterome | Biotech | France | 2016 |
| Ervimmune | Biotech | France | 2022 |
| Federation Bio | Biotech | US | 2022 |
| Foodsmart | Biotech | US | 2021 |
| Impeto Medical | MedTech | France | 2016 |
| Kainova Therapeutics | Healthcare | Canada | 2026 |
| Kapsera | Healthcare | France | 2023 |
| Kebony | Biotech | Norway | 2022 |
| La Vie | Biotech | France | 2022 |
| Larq | Biotech | US | 2020 |
| Lecturio | Business Services | Germany | 2020 |
| MaaT Pharma | Biotech | France | 2026 |
| Machtfit | Biotech | Germany | 2018 |
| Mainstay | MedTech | Ireland | 2022 |
| Mauna Kea | MedTech | France | 2015 |
| MedEye | MedTech | Netherlands | 2019 |
| MedinCell | Healthcare | France | 2017 |
| Microbiotica | Biotech | UK | 2026 |
| Myco Technology | Biotech | US | 2020 |
| Nexess | Telecom | France | 2016 |
| Nimble Sciences | Biotech | Canada | 2023 |
| Novobind | Healthcare | Canada | 2022 |
| One Bio ex BCD... | Biotech | US | 2022 |
| Peptobiotics | Healthcare | Singapore | 2023 |
| Proteon... | Healthcare | Poland | 2022 |
| Protip | MedTech | France | 2016 |
| Quanta | MedTech | UK | 2023 |
| Sequentia | FoodTech | Spain | 2023 |
| Siolta Therapeutics | Biotech | US | 2020 |
| Standing Ovation | Biotech | France | 2026 |
| Starfish | Biotech | France | 2023 |
| Sunrise | MedTech | Belgium | 2024 |
| Targedys | Biotech | France | 2019 |
| Testbirds | Business Services | Germany | 2018 |
| The Akkermansia... | Biotech | Belgium | 2020 |
| Vedanta | Biotech | US | 2020 |
| Vertero... | Biotech | US | 2023 |
Quadrivium 1 Seed FundVC2013 · 13yr€56M8 active · 1 realized
Unrealized
8 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Acarix | MedTech | Denmark | 2018 |
| Algoan | Fintech | France | 2020 |
| Artifakt | Business Services | France | 2021 |
| Dashbook | E-commerce | France | 2022 |
| Feetme | MedTech | France | 2018 |
| FIRE1 | MedTech | UK | 2021 |
| Galecto Biotech | Healthcare | Denmark | 2018 |
| Humedics | MedTech | Germany | 2019 |
Spef Pre-IPOVC2007 · 19yr€30M1 active
Unrealized
1 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Endocontrol | MedTech | France | 2017 |
Saved GPs appear in your watchlist, one click from your workspace.
About Seventure Partners
Seventure Partners is a European venture capital firm with €1 billion of assets under management as of June 2024, founded in 1997 and headquartered in Paris. The firm specialises in Digital and Life Sciences themes with global recognition as a leading microbiome-focused investor through dedicated themed funds. Seventure operates as part of Natixis Investment Managers within the broader Groupe BPCE financial group.
Investment thesis
Seventure deploys venture capital across two complementary themes: Digital (enterprise software, fintech, digital media) and Life Sciences (biotech, MedTech, HealthTech with particular depth in microbiome and nutrition themes). Investment stages span early-stage seed and Series A through growth equity commitments. The microbiome thematic franchise distinguishes Seventure as one of the few European VCs with dedicated capital for that emerging scientific vertical, with equity tickets typically ranging from €1 million to €15 million per transaction.
Recent activity
Recent realised exits include 365Talents (business services, 2026), Saagie (business services, 2025), Medius Expensya (fintech, 2023) and Polaris (biotech, 2023), reflecting active distribution across the technology and life sciences franchises. The platform tracks 10 funds and 126 active portfolio companies across the multi-decade European VC programme. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.